Erythroblastosis, Fetal

Displaying 1 - 2 of 2CSV
Moise, K. J., Ling, L. E., Oepkes, D., Tiblad, E., Verweij, E. J. T. J., Lopriore, E., Smoleniec, J., Sachs, U. J., Bein, G., Kilby, M. D., Miller, R. S., Devlieger, R., Audibert, F., Emery, S. P., Markham, K., Norton, M. E., Ocón-Hernández, O., Pandya, P., Pereira, L., … Bussel, J. B. (2024). Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn. New England Journal of Medicine, 391(6), 526–537. https://doi.org/10.1056/nejmoa2314466
Publication Date
Jajosky, R. P., Patel, K. R., Allen, J. W. L., Zerra, P. E., Chonat, S., Ayona, D., Maier, C. L., Morais, D., Wu, S.-C., Luckey, C. J., Eisenbarth, S. C., Roback, J. D., Fasano, R. M., Josephson, C. D., Manis, J. P., Chai, L., Hendrickson, J. E., Hudson, K. E., Arthur, C. M., & Stowell, S. R. (2023). Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression. Blood, 142(12), 1082–1098. https://doi.org/10.1182/blood.2022018591
Publication Date